Recent Headlines
Within Biotechnology
Medical Marketing and Media Names Arteric an Agency to Watch
Healthcare Digital Marketing Agency Recognized for Award-Winning, Ground-Breaking Work. - July 17, 2018 - Arteric
ALPCO Releases STELLUX® Chemi Active GLP-1 (7-36) Amide ELISA to Accurately Quantify Fasted Levels
ALPCO, a leading producer of research and clinical immunoassays, recently announced the launch of its STELLUX® Chemi Active GLP-1 (7-36) amide ELISA. The chemiluminescence ELISA features increased sensitivity to accurately quantify active GLP-1 (7-36) amide levels as low as 1.5 pg/mL with a 25... - July 17, 2018 - ALPCO
NuvOx Pharma Receives $2M SBIR Grant for Pancreatic Cancer Diagnostic Development
Evan Unger, MD, President and CEO of NuvOx Pharma, announced that NuvOx has received a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute to fund the development of a new strategy to detect pancreatic cancer. The grant, 2R44CA203090-02, entitled... - July 14, 2018 - NuvOx Pharma
AdvantaPure® Introduces New Case Studies on Tubing, Closures and Molded Assemblies; Each Study Describes Processing Problems, Customer Goals, and Product Solutions
Three new case studies from AdvantaPure highlight fluid transfer challenges in the biopharm and pharmaceutical industries. One study explores leak-proof container systems coupled with the goal of foam reduction. Another focuses on Single-Use molded tubing assemblies in a final fill application. The third examines how a customer decided between movable totes and two styles of clean room wall pass-through systems. - July 14, 2018 - AdvantaPure
Arteric.com Continues to Garner Accolades
4 Communicator Awards Raise Total to 8 Trophies From 3 Competitions - July 10, 2018 - Arteric
ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 22-26, 2018 in Orlando, FL. - June 19, 2018 - ALPCO
APDM Wearable Technologies Awarded NIH Funding to Commercialize Novel Biofeedback System
APDM Wearable Technologies has been awarded a National Institute on Aging SBIR Phase II grant totaling $1.6 million to commercialize a real-time biofeedback system. With this funding, APDM will develop the industry's first over-ground gait biofeedback rehabilitation system utilizing both visual and... - June 19, 2018 - APDM Wearable Technologies
AdvantaPure® Completes Full BPOG Extractables Testing of Several Silicone and TPE Tubing Products; Provides Drug Manufacturers with Extensive Test Results for Comparison
Tubing manufacturer AdvantaPure announces the completion of BPOG testing on three of its tubing lines used for biopharm and pharmaceutical applications. Two styles of silicone tubing – standard and high pressure – and the company’s weldable and sealable TPE tubing now offer full BPOG test results for extractable compounds. Tests were performed by a fully-accredited, third-party test lab using a variety of analytical techniques. Results are available upon request. - June 14, 2018 - AdvantaPure
PuRxCell Names Medical Director for Taiwan
PuRxCell Offers Physicians Stem Cell Training, Protocols and Products. - June 12, 2018 - PuRxCell
Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing at Digital Pharma West
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - June 08, 2018 - Arteric
Arteric.com Named Best Marketing Website and Best Professional Services Website
Latest Awards Follow Wins for Mobile Website Design. - June 06, 2018 - Arteric
MoBiTec GmbH Teams Up with ABP Biosciences, US, to Offer Superior Fluorophores at Reasonable Prices
ABP Biosciences invents, develops, and markets innovative products and technologies to scientists engaged in life sciences research, diagnostic R&D, and drug discovery. ABP specializes in the area of fluorescence labeling and detection technologies. - June 06, 2018 - MoBiTec GmbH
AdvantaPure(R) Contributes to Newly-Released Forecasting and Supply Planning Guide from BPOG; Combined Effort Aims to Improve Forecasting and Demand Planning
BPOG, the BioPhorum Operations Group, recently developed a best practices guide on forecasting and demand planning involving the biopharmaceutical industry. The guide, a collaborative effort involving biomanufacturers and suppliers, is available from BPOG’s website. It aims to help manufacturers and their vendors improve understanding and communication regarding each other’s needs. A self-assessment tool for measuring companies’ current planning processes is also available from the site. - June 01, 2018 - AdvantaPure
Mercodia Launches Unique Quality System
The immunoassay company Mercodia today announces the launch of MAQS – the Mercodia Assay Quality System. With this program, Mercodia is the first company in the field of immunoassays to set a standard for quality, ensuring customer satisfaction in all parts of its offers. Today, many... - May 17, 2018 - Mercodia AB
Virun® NutraBIOsciences® and Algarithm™ Ingredients Launch O3Omega™ Smoothies in Canada; Patent for Viruns' Spray-Dry Technology Receives Notice of Allowance in U.S.
Virun® NutraBIOsciences® and Algarithm™ Ingredients Announce O3Omega™ Smoothies Line Picked Up by Canadian Retail Giant Co-op so People Can Enjoy Plant-Based Omega 3s Every Day, the Easy Way, Notice of Allowance for Patent Covering Spray-Dried Powders Containing Non-Polar Compounds. - May 10, 2018 - VIRUN
Apostle Inc Announces Acceptance Into the StartX Accelerator Program
Apostle Inc is pleased to announce it’s been accepted into the prestigious StartX accelerator program. StartX is a renowned educational non-profit that accelerates the development of Stanford's top entrepreneurs through experiential education and collective intelligence. The acceptance rate has been between 8%-10%. - May 05, 2018 - Apostle Inc
Artificial Intelligence: Hype or Help for Healthcare Marketers?
Arteric's President Shares How AI Detects Important Signals of Audience Behavior - May 04, 2018 - Arteric
LayerBio to Present Preclinical Results for Extended Release Glaucoma Formulation at ARVO
LayerBio will present preclinical study results at the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii on Monday, April 30. These results demonstrate the therapeutic potential of its novel extended-release travoprost formulation using LayerBio's proprietary PolyNet™ delivery technology. - April 27, 2018 - LayerBio, Inc.
BioDivide Ltd, a Stem Cell Company, Announces New Website Launch
The new website offers visitors rich insights into the Company’s lead stem cell product, StemPlan, and applied expertise of the therapeutic and biotechnology applications of stem cells. The website also provides a complete overview of the Company’s GMP facilities and service offerings engineered to harness the power of stem cells and regenerative medicine. - April 18, 2018 - BioDivide Limited
New Purpose-Built MaxSpec™ Standards Available for Quantitative Mass Spectrometry Analysis
Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more... - April 18, 2018 - Cayman Chemical Company
Leveraging AI to Help Healthcare Marketers Detect Signals of Audience Behavior
Arteric's President and Chief Strategist Shares Case Studies and Insights. - April 16, 2018 - Arteric
D.L. Newslow & Associates, Inc. Announces Partnership with Savour Food Safety International, Inc.
Two food safety and management systems consulting and training powerhouses are teaming up to take you to the next level. The professional partnership between D.L. Newslow & Associates and Savour Food Safety International brings an exciting and dynamic new angle to the industry, with a fresh face of service to manufacturing companies across the U.S. and beyond. - April 11, 2018 - D.L. Newslow & Associates, Inc.
Tornado Spectral Systems Announces Feature-Packed Software Update with SpectralSoft 2.8
Security, Productivity, and Industrial Control Modules included in latest version. Tornado Spectral Systems Inc., a leading manufacturer of Raman spectrometers, released today an enhanced update of its flagship software SpectralSoft. Version 2.8 equips users with essential functionality including... - April 11, 2018 - Tornado Spectral Systems
Second Patent Awarded for AdvantaPure(R)’s AdvantaPass(R) Clean Room Wall Pass-Through System
AdvantaPure has been issued a second U.S. patent for its AdvantaPass technology. The system maintains the separation of room atmospheres to minimize contamination risks in biopharm and pharmaceutical processing. Improvements that warranted the second patent include welded wall portals, the elimination of adhesives and sealants and adjustable wall flanges. The upgrades offer users more options regarding mounting and using the system. - April 06, 2018 - AdvantaPure
Growing In Vitro Diagnostics (IVD) Market to Set New Business Opportunities for Start Up Company
Vidan Diagnostics Expected to Provide Access to Unique Tests Related to Monitoring of Diabetes and Sepis. - April 05, 2018 - Vidan Diagnostics, LLC
Apostle Inc Announces Joint Venture with Southern University of Science and Technology in the Greater China Region
Apostle Inc is pleased to announce the launch of a joint venture with Southern University of Science and Technology (SUSTech) in Shenzhen, China. The joint venture, Apostle-SUSTech Inc, will focus on the scientific and business activities in the Greater China region. David Ge, President of Apostle... - April 04, 2018 - Apostle Inc
Proteos, Inc. Honored as One of the 2018 “Best Small Business Honorees”
Proteos, Inc. has been recognized as one of the 2018 “Best Small Businesses,” an awards program presented by Michigan Celebrates Small Business. Proteos will receive the SmartZone Best Small Business of the Year Award and be honored at an awards ceremony during the fourteenth annual... - March 24, 2018 - Proteos
PuRxCell Names Medical Director for the Philippine Islands
PuRxCell Offers Physicians Stem Cell Training, Protocols and Products. Robert J. Colucci CEO of PuRxCell, LLC, a Florida based company, announced today that PuRxCell, has named Dr. Jeimylo C. de Castro as its Medical Director for the Philippine Islands and parts of Asia. “Doctor de Castro... - March 23, 2018 - PuRxCell
NCHQA's Choosing Wisely® in NC Program Significantly Reduces Unnecessary Medical Tests and Antibiotic Overuse
The Choosing Wisely® in North Carolina initiative – which aims to reduce health care waste by helping patients make smart and effective health care choices – has resulted in significant reductions in the unnecessary use of antibiotics, Pap tests and scans for osteoporosis. - March 23, 2018 - NCHQA
Leveraging AI to Uncover Signals of Audience Behavior for Healthcare Marketing
Arteric's President Shares Case Studies and Essentials for Success - March 22, 2018 - Arteric
Value Drug Scores Big in Pharmaceutical Returns
PharmaLink is the New Partner in Drug Returns Processing Value Drug, a top-rated wholesaler to independent pharmacies, announced another industry leading initiative with PharmaLink. Together they will now provide to all of their members a full array of services in the take back and processing of... - March 14, 2018 - PharmaLink
Aciont to Present Phase 1/2 Clinical Data at ARVO 2018 Annual Meeting
Aciont Inc. announced today that Dr. Kongnara Papangkorn, VP of Product Development, will be presenting clinical data of Aciont’s lead product, DSP-Visulex, from its phase 1/2 clinical trial in the treatment of noninfectious anterior uveitis (DSPV-201) at the Association for Research in... - March 10, 2018 - Aciont Inc.
ClinSearch Announces Transition in Leadership Team Welcomes Mark M. McKenzie, M.D. as Medical Director
ClinSearch, Clinical Research Specialists announces a transition in leadership at the 25-year-old clinical research site. Dr. Mark M. McKenzie is succeeding ClinSearch founder Dr. Richard A. Krause as medical director. “I have a passion for medical care and the difference it makes in the... - March 10, 2018 - Wake Research Associates
Virun® NutraBIOsciences® Announces Sponsorship of Upcoming Top Shelf Tech Fest 2018, a Music & Technology Festival Celebrating Innovation with Food Technology and Music
Virun® NutraBIOsciences® Showcases Hot Young Musical Talent, Hosts Informative Panel Discussions and Presents its’ New Product Offering to the Masses at Inaugural Music and Food Science Event. - March 01, 2018 - VIRUN
Leader Biomedical Announces Acquisition of International Orthopaedics Holding GmbH
Leader Biomedical is pleased to announce the phased acquisition of International Orthopaedics Holding GmbH (International Orthopaedics), a manufacturer and distributor of orthopaedic implants based in Geisingen, Germany. The companies have entered into a notarial deed on the 20th of February, 2018. - March 01, 2018 - Leader Biomedical
cliexa® Partners with Institute of Cognitive Science at University of Colorado Boulder
cliexa® partners with the University of Colorado Boulder's Cognitive and Affective Neuroscience Lab (CANLab) for Multidimensional Pain Tracking and Predictive Analytics Research. - February 28, 2018 - cliexa
Experimentica Ltd. Amongst the Most Promising Finnish Young Innovative Companies
Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12... - February 21, 2018 - Experimentica Ltd
Apostle Inc Appoints Alexander Hartemink, PhD at Duke University to Scientific Advisory Board
Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. Dr. Hartemink is Professor of Computer Science and Biology at Duke University. He is the faculty director of the Office of Undergraduate Scholars and Fellows and the... - February 19, 2018 - Apostle Inc
US Patent Issued on CPSI’s FrostBite™ Pancreas Cancer Cryoablation Catheter
Latest patent covers an endoscopic-based cryocatheter (FrostBite™) designed to provide an advanced approach for targeting pancreatic and other gastroenterological based cancers. - February 15, 2018 - CPSI Biotech
Steven Levy at MD Stem Cells Tapped for International Conference on Biological Information & Biomedical Engineering
Study Director for multiple stem cell studies continues contributions to international scientific community. - February 13, 2018 - MD Stem Cells
Stem Cell Ophthalmology Treatment Study Releases Data on ClinicalTrials.gov Website
MD Stem Cells publishing positive, statistically significant results on treatments in SCOTS. - February 13, 2018 - MD Stem Cells
MD Stem Cells Announces New Spinal Cord Stem Cell Treatment Combined with Exoskeleton and Virtual Reality
MD Stem Cells coordinates latest technologies to advance stem cell treatment of paraplegia. - February 12, 2018 - MD Stem Cells
Apostle Inc Appoints David B. Goldstein, PhD at Columbia University to Scientific Advisory Board
Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. Dr. Goldstein is John E. Borne Professor of Medical and Surgical Research at Columbia University. - February 11, 2018 - Apostle Inc
Oxford Optronix Ltd. and Scintica Instrumentation Inc. Proudly Announce Agreement on Official Product Distribution for North America
With highly qualified sales and support staff covering both Canada and the United States and extensive expertise in supplying the life sciences with novel and high quality scientific instrumentation, Scintica is perfectly placed to partner with Oxford Optronix. The Scintica team consists of... - February 07, 2018 - Scintica Instrumentation
Proteos Moves Toward Employee Ownership
Proteos, Inc. announced on Monday January 29, 2018 that the company would begin the process of restructuring and transitioning to a majority employee-owned corporation. Since its founding in 2003, by Clark W. Smith, Ph.D. and Robert L. Heinrikson, Ph.D., Proteos has been committed to both customer... - February 03, 2018 - Proteos
Improving the Health of South Asians Across the Globe
Many people are looking at their parents, grandparents and families and seeing cancer, diabetes, heart disease and rare diseases, all of which can have a genetic component. South Asians have twice the rate of genetic disease compared to the rest of the world, yet there is far less data, less than 1% of the available data. So people don’t know what they are carrying, and they want better diagnosis and treatments for their family members. #MaptheGap will start to address this. - February 02, 2018 - Map the Gap
Phelix Therapeutics, LLC Awarded Phase I SBIR Grant from NIH to Develop Calpain Therapeutics for Idiopathic Pulmonary Fibrosis
Phelix Therapeutics, LLC is pleased to announce it has received a $201,665 grant from the National Institutes of Health (NIH). This Small Business Innovation Research (SBIR) funding will support Phelix’s continued research of Calpain therapeutics to inhibit myofibroblast generation in... - January 31, 2018 - Phelix Therapeutics, LLC
InBody Will Provide Free Body Composition Tests to Border Security Expo Attendees, January 31 to February 1
Visitors will also receive a free consultation at the body composition analyzer’s booth (#409) in the Henry B. Gonzalez Convention Center in San Antonio, TX. - January 31, 2018 - InBody
NanoHybrids Launches Revolutionary Contrast Agent to Measure EPR Effect at 2018 SPIE BiOS Expo
NanoHybrids, announces the launch of PAtrace, a proprietary nanoparticle that provides high resolution visualization and verification of the enhanced permeability and retention (EPR) effect in heterogeneous tumor models. PAtrace is being launched at the 2018 SPIE BioS Expo. - January 29, 2018 - NanoHybrids
Eagle Biosciences Introduces New Intact FGF23 ELISA Assay Kit
Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.